Article Text

other Versions

PDF
Renin: friend or foe?
  1. Morris J Brown (mjb14{at}medschl.cam.ac.uk)
  1. University of Cambridge, United Kingdom

    Abstract

    Key points

    • The main physiological role of the renin angiotensin system (RAS) is to protect against Na+ loss, and the hypotension which results. When inappropriately high for the level of Na+ in the body, renin production can contribute to hypertension and end-organ damage.

    • Renin secretion is regulated by four mechanisms: arterial pressure, sympathetic nervous system activity, salt intake and negative feedback regulation by Ang II.

    • Most antihypertensive medications influence the measurement of plasma renin activity (PRA), acting on one of the above mechanisms. ACE inhibitors, ARBs, CCBs and diuretics increase PRA, whereas beta-blockers and renin inhibitors reduce PRA.

    • At the population level, PRA is negatively correlated with age and Na+ intake, and therefore also with blood pressure. In many patients with hypertension, however, PRA is inappropriately high for the level of Na+ intake, and limits the effectiveness of drugs used to eliminate Na+.

    • In hypertension, therefore, it is rational to combine drugs which, respectively, eliminate Na+ and block the RAS. Combination treatment is likely to become routine even for initial treatment of most patients, and will improve rates of BP control.

    • In high-renin states, namely heart failure, strategies to increase RAS suppression (e.g. ACE inhibitor/ARB combination therapy) can improve treatment outcomes. In other conditions, benefits are proportional to the prior contribution of renin to a patient’s hypertension or other cardiovascular risk.

    • Measurement of renin is now straightforward. In addition to diagnosis of secondary causes of hypertension, the measurement permits recognition and titration of the low-renin patient in whom extra diuretic is required to de-suppress renin secretion and potentiate further RAS blockade.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Editorial
      Milan Gupta Subodh Verma G B John Mancini